(Q73507692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

[Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

hypertrophic cardiomyopathy

4 November 2019

main subject

1 reference

W J McKenna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L Monserrat Iglesias

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

Revista Española de Cardiología

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

123-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

The management of hypertrophic cardiomyopathy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Hypertrophic cardiomyopathy: an important cause of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Genotype–phenotype correlations in familial hypertrophic cardiomyopathy A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Sudden death due to troponin T mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Genes and disease expression in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

QT-interval abnormalities in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Diurnal change in QT intervals in dilated cardiomyopathy and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Heart rate variability in patients with hypertrophic cardiomyopathy: association with clinical and echocardiographic features

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975069-X

7 January 2021

10.1016/S0300-8932(00)75069-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10701329%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference